3Gerolami R, Cardoso J, Lewin M, et al. Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratmnoral and intrahepatic artery routes. Cancer Res, 2000, 60: 993-1001.
4Seol JG, Heo DS, Kim HK, et al. Selective gene expression in hepatic tumor with trans-arterial delivery of DNA/liposome/tranferrin complex.In Vivo, 2000, 14: 513-517.
5Drozdzik M, Qian C, Xie X, et al. Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma. J Hepatol, 2000, 32:279-286.
6Rak JW, St Croix DB, Kerbel RS. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anti Cancer Drugs,1995, 6: 3-18.
7Augustin HG. Antiangiogenic tumor therapy: will it work? Trends Pharmacol Sci. 1998. 19: 216-222.
8O'reilly MS, Boehm T, Siting Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997, 88: 277-285.
10Koyama H, Nishizawa Y, Hosoi M, et al. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-Ⅰ : possible involvement of cyclin-dependent kinase 2. Cirr Res, 1996, 79: 757-764.
